Related Experiment Video
Updated: Apr 5, 2026
06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
9.3K
Does molecular monitoring matter in early-stage breast cancer?
Tilak K Sundaresan1, Daniel A Haber2
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02129, USA. Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Science Translational Medicine
|August 28, 2015
Abstract:
Serial monitoring of circulating tumor DNA predicts recurrence after treatment for localized breast cancer (Garcia-Murillas et al., this issue).
